Engineering an Antibody V Gene-Selective Vaccine
The ligand-binding surface of the B cell receptor (BCR) is formed by encoded and non-encoded antigen complementarity determining regions (CDRs). Genetically reproducible or ‘public’ antibodies can arise when the encoded CDRs play deterministic roles in antigen recognition, notably within human broad...
Main Authors: | Larance Ronsard, Ashraf S. Yousif, Julianne Peabody, Vintus Okonkwo, Pascal Devant, Alemu Tekewe Mogus, Ralston M. Barnes, Daniel Rohrer, Nils Lonberg, David Peabody, Bryce Chackerian, Daniel Lingwood |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.730471/full |
Similar Items
-
RNA Phage VLP-Based Vaccine Platforms
by: David S. Peabody, et al.
Published: (2021-08-01) -
A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2.
by: Ebenezer Tumban, et al.
Published: (2011-01-01) -
Epitope-Specific Anti-hCG Vaccines on a Virus Like Particle Platform.
by: Jerri Caldeira, et al.
Published: (2015-01-01) -
VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus.
by: Ebenezer Tumban, et al.
Published: (2012-01-01) -
Factors That Govern the Induction of Long-Lived Antibody Responses
by: Bryce Chackerian, et al.
Published: (2020-01-01)